Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
LNCB74 for Cancer
Recruiting1 awardPhase 1
San Antonio, Texas
This trial is testing a new drug called LNCB74 in patients with advanced solid tumors to see how safe and well-tolerated it is, and to find the highest safe dose for future studies
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service